Endometrial Cancer Recurrent
📧 Sign up to get email alerts when something new happens for Endometrial Cancer Recurrent.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer [Phase 2]
Phase 2 study evaluating durvalumab with or without tremelimumab in endometrial cancer and carcinosarcoma has completed with results posted.